We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Selegiline reduces N-methyl-D-aspartic acid induced perturbation of neurotransmission but it leaves NMDA receptor dependent long-term potentiation intact in the hippocampus.
- Authors
Niittykoski, M.; Haapalinna, A.; Sirviö, J.
- Abstract
Summary. This study examined the effects of monoamine oxidase (MAO) inhibitors on N-methyl-D-aspartic acid (NMDA)-induced perturbation of neurotransmission and normal NMDA-receptor dependent function (long-term potentiation, LTP) in the CA1 field of hippocampus. During baseline recording, neurotransmission was unaffected by long-term bath perfusion with MAO inhibitors (selegiline, pargyline). After NMDA (100 µM) infusion, the presence of selegiline (1 µM) promoted the recovery rate and increased the size of recovered extracellular field excitatory postsynaptic potentials (fEPSPs). Selegiline (1 µM) also prevented the NMDA-induced increase in paired pulse facilitation (PPF). The induction and maintenance of LTP were normal with this same concentration of selegiline. The presence of lower concentration (10 nM) of selegiline or pargyline (1 µM) did not improve the recovery process. These results suggest that selegiline partially protects the function of CA3-CA1 hippocampal connections against overactivation of NMDA receptors. Further, the same concentration of selegiline does not interfere with the physiological function of NMDA receptors in the CA1 field of the hippocampus. The exact mechanism of action remains to be determined, but it is apparently downstream to the overactivation of NMDA receptors.
- Subjects
SELEGILINE; NEURAL transmission; METHYL aspartate; ASPARTIC acid; HIPPOCAMPUS (Brain); MONOAMINE oxidase inhibitors
- Publication
Journal of Neural Transmission, 2003, Vol 110, Issue 11, p1225
- ISSN
0300-9564
- Publication type
Article
- DOI
10.1007/s00702-003-0035-5